Frederick Graham, MD
Physical Medicine & Rehabilitation · Northport, ALNPI 1548212954
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,580 of the $4,475 with a category attached, or 80.0%. It is spread thinly across 31 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,780 and has fallen 92.7% since, to $130 in 2025. Among physical medicine & rehabilitation clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$1K
- Medtronic$748
- Collegium Pharmaceutical, Inc.$578
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$281
- Amgen$254
- Scilex Pharmaceuticals Inc.$232
- plus $1K from 25 others
What the payments were for
- Travel & lodging$89320%
- Food & beverage$3,58080%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 10 | $1,055 |
| Medtronic(2 entities) | 47 | $748 |
| Collegium Pharmaceutical, Inc. | 34 | $578 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $281 |
| Amgen(2 entities) | 16 | $254 |
| Scilex Pharmaceuticals Inc. | 13 | $232 |
| Forte Bio-pharma LLC | 5 | $224 |
| Almatica Pharma LLC | 9 | $172 |
| Biodelivery Sciences International, Inc. | 7 | $106 |
| IBSA Pharma Inc. | 5 | $90 |
| Boston Scientific | 5 | $76 |
| Pfizer | 5 | $64 |
| Assertio Therapeutics, Inc. | 4 | $61 |
| Arbor Pharmaceuticals, Inc. | 4 | $59 |
| Redhill Biopharma Inc. | 3 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
| Abbott | 3 | $46 |
| Relievant Medsystems, Inc. | 3 | $37 |
| Virtus Pharmaceuticals LLC | 2 | $34 |
| GRT US Holding, Inc. | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $30 |
| Nevro Corp. | 1 | $28 |
| Stimwave Technologies Incorporated | 2 | $27 |
| Curonix LLC | 1 | $26 |
| Avanos Medical | 1 | $22 |
| Bioventus LLC | 1 | $17 |
| Shionogi Inc | 1 | $17 |
| Baudax Bio Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| MDD US Operations, LLC | 1 | $11 |
| Si-bone, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$732
- Prolate$501
- Nalocet$125
How this compares
$4,475 in reported general payments places this provider in the 90th percentile of 104 physical medicine & rehabilitation providers in Alabama.
See all physical medicine & rehabilitation providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 5,520 | $112,736 |
| Xtampza ErOxycodone Myristate | 128 | $76,395 |
| Oxycodone Hcl | 2,137 | $37,235 |
| Gabapentin | 2,108 | $27,741 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 952 | $25,759 |
| Lidocaine | 152 | $23,188 |
| OxycontinOxycodone Hcl | 52 | $22,385 |
| ZtlidoLidocaine | 26 | $19,696 |
| MovantikNaloxegol Oxalate | 35 | $18,436 |
| NucyntaTapentadol Hcl | 16 | $16,261 |
| BelbucaBuprenorphine Hcl | 18 | $8,757 |
| Fentanyl | 95 | $8,145 |
| Pregabalin | 571 | $7,515 |
| Methocarbamol | 825 | $7,243 |
| Nucynta ErTapentadol Hcl | 12 | $7,094 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Belbuca, Nucynta Er | $578 | $108,507174 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $232 | $19,69626 claims |
| Redhill Biopharma Inc.Movantik | $54 | $18,43635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 104 physical medicine & rehabilitation providers in Alabama.
Other physical medicine & rehabilitation in Northport
- James BarnettNorthport$1K
- Vinayak MemulaNorthport$437
- Don McCormickBirmingham$22K
- Bradly GoodmanBirmingham$15K
- Nelson Santos AgostoBirmingham$14K
- John PantuoscoBirmingham$12K
- Ross LumsdenBirmingham$11K
- Michael RosemoreBessemer$10K
- Stevon BoyettAthens$8K
- David ThomasonDaphne$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.